Table 2.
Effect of glutathione and liposomal glutathione on clinical investigations following pristane administration.
| Groups | ||||
|---|---|---|---|---|
| Parameter | Control | Pristane | Glutathione | Liposomal glutathione |
| Score of toe deformation | 0a | 56.4 ± 2.1b | 29.2 ± 1.6c | 20.3 ± 1.3d |
Data are expressed as means ±S.E.M (n = 10). P-value <0.05 is considered significant. Groups having the same letter are not significantly different, while those having different letters are significantly different from each other.